VTAK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Catheter Precision Inc (VTAK) is not a strong buy at this time for a beginner investor with a long-term strategy. Despite recent financing efforts and growth initiatives, the technical indicators are bearish, financial performance shows significant losses, and there are no clear trading signals or positive catalysts to support immediate investment.
The stock shows bearish technical indicators: MACD is negative and expanding downward, RSI is neutral at 33.136, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The current price is below the pivot level of 1.64, with key support at 1.311 and resistance at 1.969.
The company has secured $36.5 million in financing, converted short-term notes into long-term debt, and is reducing liabilities by converting $9 million into equity. These measures aim to improve financial stability and support growth initiatives.
The company reported a significant net income loss of -$2.25 million in Q3 2025, with EPS dropping by -95.55% YoY. Technical indicators are bearish, and there are no significant hedge fund or insider trading trends to suggest strong institutional confidence.
In Q3 2025, revenue increased by 135.42% YoY to $226,000, but net income dropped to -$2.25 million (-45.36% YoY), and EPS fell to -1.7 (-95.55% YoY). Gross margin improved slightly to 92.04% (+2.75% YoY), but overall financial performance remains weak.
No analyst rating or price target data available.
